Medicare Enrolled
Dr. Achraf Makki, M.D.
Neurology · Panama City, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Makki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Makki?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Makki
Dr. Achraf Makki is a neurology specialist in Panama City, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Makki performed 4,391 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Makki received a total of $75,733 from 62 pharmaceutical and/or device companies across 440 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Makki is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 15% volume in FL
$75,733 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 100627 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗4,391
Medicare services
Top 15% in FL for neurology
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
997 | $0 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
779 | $91 | $260 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
437 | $67 | $185 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
380 | $75 | $201 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
310 | $64 | $156 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
303 | $95 | $235 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
180 | $128 | $342 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
159 | $133 | $375 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
135 | $118 | $735 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
90 | $40 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
86 | $123 | $324 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
85 | $85 | $210 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
64 | $96 | $260 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
63 | $146 | $452 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
51 | $194 | $885 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
51 | $103 | $645 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
40 | $46 | $120 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
37 | $43 | $90 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
32 | $212 | $762 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
32 | $161 | $448 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
31 | $112 | $609 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
29 | $55 | $155 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
20 | $86 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$75,733
Total received (2020-2024)
Avg $15,147/year across 5 years
Top 7% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
440
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$291
2023
$14,047
2022
$36,184
2021
$25,118
2020
$92
Payments by company (2024)
GE HEALTHCARE
$70
MDD US Operations, LLC
$66
PFIZER INC.
$49
Octapharma USA, Inc.
$41
Lilly USA, LLC
$27
Grifols USA, LLC
$21
Biogen, Inc.
$18
Top 3 companies account for 63.3% of 2024 payments
All-time payments by company (2020-2024) ›
ABBVIE INC.
$44,177
AbbVie Inc.
$21,306
Allergan, Inc.
$1,801
ARGENX US, INC.
$1,492
Biogen, Inc.
$397
JAZZ PHARMACEUTICALS INC.
$375
Novartis Pharmaceuticals Corporation
$361
Lilly USA, LLC
$302
Biohaven Pharmaceuticals, Inc.
$300
PFIZER INC.
$289
UCB, Inc.
$265
Lundbeck LLC
$225
Abbott Laboratories
$222
Genentech USA, Inc.
$210
SK Life Science, Inc.
$208
Alexion Pharmaceuticals, Inc.
$206
Teva Pharmaceuticals USA, Inc.
$202
Nevro Corp.
$189
Horizon Therapeutics plc
$177
Harmony Biosciences LLC
$174
Grifols USA, LLC
$169
Greenwich Biosciences, Inc.
$166
ACADIA Pharmaceuticals Inc
$153
IMPEL PHARMACEUTICALS INC.
$151
Amgen Inc.
$137
Biohaven Pharmaceutical Holding Company Ltd.
$129
CSL Behring
$125
Octapharma USA, Inc.
$120
Celgene Corporation
$113
MDD US Operations, LLC
$103
Bayer HealthCare Pharmaceuticals Inc.
$100
Sunovion Pharmaceuticals Inc.
$92
GE HEALTHCARE
$91
GENZYME CORPORATION
$86
MITSUBISHI TANABE PHARMA AMERICA, INC.
$85
Alnylam Pharmaceuticals Inc.
$75
Otsuka America Pharmaceutical, Inc.
$74
Catalyst Pharmaceuticals, Inc.
$68
Merck Sharp & Dohme LLC
$66
EISAI INC.
$61
EMD Serono, Inc.
$59
Acorda Therapeutics, Inc
$58
Avanir Pharmaceuticals, Inc.
$50
Boston Scientific Corporation
$50
BOSTON SCIENTIFIC CORPORATION
$45
Merck Sharp & Dohme Corporation
$43
Supernus Pharmaceuticals, Inc.
$41
Amneal Pharmaceuticals LLC
$38
Collegium Pharmaceutical, Inc.
$35
Medtronic, Inc.
$31
BioDelivery Sciences International, Inc.
$28
SI-BONE, INC.
$23
CATALYST PHARMACEUTICALS, INC.
$23
UPSHER-SMITH LABORATORIES LLC
$23
Sumitomo Pharma America, Inc.
$20
Neurelis, Inc.
$20
GRT US Holding, Inc.
$19
Merz Pharmaceuticals, LLC
$19
Eisai Inc.
$18
IDORSIA PHARMACEUTICALS US INC
$17
Xeris Pharmaceuticals, Inc.
$16
LivaNova USA, Inc.
$16
Top 3 companies account for 88.8% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BELBUCA · BELSOMRA · BOTOX · Briviact · COMIRNATY · CUTAQUIG · EMGALITY · EPIDIOLEX · Epidiolex · Evrysdi · FIRDAPSE · Fintepla · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · Gocovri · Hizentra · IFUSE IMPLANT · INBRIJA · INFINITY · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · Kerendia · MAYZENT · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OXTELLAR XR · Ocrevus · PANZYGA · PAXLOVID · PROCLAIM · QULIPTA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · RYTARY · SOLIRIS · SPINRAZA · SUNOSI · Senza · TECFIDERA · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS - Sentiva · VUMERITY · VYEPTI · VYVGART · Vercise · WAKIX · Wakix · XCOPRI · XTAMPZA · XYWAV · Xeomin · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
9
County median income
$70,188
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA GULF COAST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Makki is a clinical cardiology specialist, with above-average Medicare volume (top 15% in FL), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Makki experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Makki performed 997 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Makki receive payments from pharmaceutical companies?
Yes. Dr. Makki received a total of $75,733 from 62 companies across 440 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Makki's costs compare to other neurologists in Panama City?
Dr. Makki's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Makki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Panama City
Browse neurologists in Panama City ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology